Evaluation, management, and long-term care of patients with venous thromboembolism (VTE) requires the efforts of a multidisciplinary team, including primary care NPs and PAs. This activity takes the learner through three interactive case studies that examine how best to work up suspected VTE—both deep vein thrombosis and pulmonary embolism—how to risk stratify patients, and when, how, and how long to use anticoagulants.
Case studies with interactive benchmarking
After completing this activity, participants should be better able to:
- Select appropriate clinical, laboratory, and imaging tools to confirm or rule out VTE
- Describe the mechanisms of action, efficacy, safety, and recommended use of newer agents for the management of VTE
- Assess the risk for recurrent VTE in order to adjust the length of anticoagulation accordingly
- Implement strategies to address management of VTE during transitions of care
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP planner: Mary Knudtson, DNSc, NP, FAAN, University of California, Irvine, Irvine, California
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until January 14, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Daniel Thibodeau, MHP, PA-C, Eastern Virginia Medical School, Norfolk, Virginia
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Tapson: advisory board/consultant/research/principal investigator: Bayer, Bristol Myers Squibb, EKOS/BTG/Boston Scientific; advisory board: Thrombolex; speakers bureau: EKOS/BTG/Boston Scientific, Janssen.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hour.
Release date: January 15, 2021
Expiration date: January 14, 2022
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 99620JS